Inactive
Simplifying IT
for a complex world.
Platform partnerships
- AWS
- Google Cloud
- Microsoft
- Salesforce
Automated OOS/OOT analysis, stability trending, and batch record review. CFR 21 Part 11 compliant audit trail on PowerVS.
01 PROBLEM STATEMENT
A pharmaceutical manufacturer with multiple production facilities managed Out-of-Specification (OOS) and Out-of-Trend (OOT) investigations through manual review. QC managers spent days analysing laboratory results, reviewing batch records, and documenting investigation narratives. Batch release was delayed pending OOS closure. Stability trending was performed quarterly using spreadsheets. CFR 21 Part 11 audit trail requirements added significant documentation burden.
02 CURRENT CHALLENGES
QC managers spent days initiating OOS investigations. Manual review of laboratory results delayed the start of every investigation.
Batch release delayed pending OOS closure. Hold time extended from days to weeks, impacting production schedules and revenue.
Stability trending performed quarterly using spreadsheets. Formulation issues and shelf-life risks detected too late to act.
CFR 21 Part 11 audit trail requirements added significant manual documentation burden to every QC decision and investigation.
03 SOLUTION OVERVIEW
STAR Systems deployed AINE Lab Data Intelligence with LIMS API: LabWare, STARLIMS, or Waters Empower for result data ingestion. ERP batch master for production context. ELN integration if present. DB2 on PowerVS with CFR 21 Part 11 electronic signature support. QC manager reviews AI-generated OOS investigation narratives before proceeding. STAR updates statistical trend models quarterly.
04 WORKFLOW PROCESS
Step 1 (LIMS Data Ingestion): Result data ingested automatically from LIMS — LabWare, STARLIMS, or Waters Empower. ERP batch master provides production context for every result.
Step 2 (OOS/OOT Detection): AI detects Out-of-Specification and Out-of-Trend results automatically. Exceptions flagged immediately for investigation without manual triage.
Step 3 (Investigation Narrative): AI generates a structured investigation narrative with root cause analysis and recommended corrective actions. QC manager receives a draft, not a blank page.
Step 4 (QC Manager Review): QC manager reviews the AI-generated narrative before the investigation proceeds. Can edit or override any section prior to approval.
Step 5 (Stability Trending): Real-time stability trending performed per formulation. Shelf-life issues and formulation drift detected months earlier than quarterly spreadsheet reviews.
Step 6 (Audit Trail Compliance): CFR 21 Part 11 electronic signature support on PowerVS DB2. Full audit trail maintained automatically for every laboratory decision and investigation action.
05 KEY FEATURES
Connects to LabWare, STARLIMS, and Waters Empower via API. Result data ingested automatically with no manual data entry required.
AI detects Out-of-Specification and Out-of-Trend results in real time. Flags exceptions for investigation immediately upon result ingestion.
Generates structured investigation narrative with root cause analysis and recommended corrective actions. QC managers review drafts rather than starting from scratch.
Real-time trending per formulation replaces quarterly spreadsheet reviews. Shelf-life issues and formulation drift detected early enough to act.
DB2 on PowerVS with electronic signature support. Full CFR 21 Part 11 compliant audit trail maintained automatically on every laboratory decision.
ELN integration available where present. ERP batch master provides production context to enrich every OOS investigation and trending analysis.
06 BUSINESS OUTCOMES
OOS Investigation Initiation Time — reduced from days to hours
Batch Review Bottleneck AI flags exceptions, humans investigate only what matters
Stability Trending formulation issues detected early, not quarterly
CFR 21 Part 11 Documentation complete audit trail with no manual effort
07 REAL-WORLD SCENARIO
| Before | After |
|---|---|
| OOS result appears in LIMS. Manual review process takes days to initiate. Investigation delayed. | OOS flagged automatically. AI generates investigation narrative. QC manager reviews within hours. |
| Batch held pending OOS closure. Release delayed 2–3 weeks. Revenue impact accumulates. | AI accelerates investigation closure. Hold time reduced to days. Revenue impact minimised. |
| Quarterly trending review. Shelf-life issue discovered only after product has reached the market. | Real-time trending flags the formulation issue 6 months early. Preventive action taken before any market impact. |
| Regulatory inspection arrives. Auditor requests full audit trail. Team scrambles to compile documentation. | Audit trail requested. CFR 21 Part 11 compliant records on PowerVS DB2. Available immediately. |
08 ROI AND VALUE JUSTIFICATION
| Value Driver | Indicative Impact | How It Is Realised |
|---|---|---|
| OOS investigation initiation time | From days to hours | AI generates investigation narrative. QC manager reviews a draft, not a blank page. |
| Batch release acceleration | Days recovered per OOS event | Faster investigation closure reduces batch hold time. Revenue impact minimised. |
| Batch rejection rate reduction | Earlier OOS detection prevents batch failure | Real-time trending flags issues. Corrective action taken before batch completion. |
| Regulatory inspection readiness | Complete CFR 21 Part 11 documentation automated | Electronic signature on PowerVS. Audit trail generated automatically with no manual effort. |
| Stability shelf-life protection | Formulation issues detected before market failure | Real-time trending surfaces issues months before expiry. Preventive action possible. |
09 NEXT STEPS
30-min call to map your LIMS landscape, ELN integration, and CFR 21 Part 11 requirements.
We identify 2–3 formulations for a 10-week pilot with live LIMS integration and stability trending.
AI-generated OOS narratives run on historical data. Investigation time reduction tracked weekly.
Batch release acceleration, rejection rate reduction, and regulatory readiness improvement measured.